FDA Grants Breakthrough Device Designation to Natera's Signatera Test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to FDA Grants Breakthrough Device Designation to Natera's Signatera Test
(NASDAQ: NTRA) Delayed: 212.07 -7.16 (3.27%)
Previous Close $219.23    52 Week High $13.80 
Open $223.71    52 Week Low $6.52 
Day High $223.71    P/E N/A 
Day Low $208.79    EPS $0.00 
Volume 811,700